Pilianidis, G. et al. (2024) “Can euglycemic diabetic ketoacidosis caused by SGLT2 inhibitors be avoided in COVID-19 and other acute infections?”, European Journal of Case Reports in Internal Medicine, 11(3). doi:10.12890/2024_004282.